Trial Profile
An open label, single dose, randomized, three period crossover study to investigate the relative bioavailability of 0.5 mg of dutasteride from soft gelatin capsules (reference) vs. soft gelatin capsules containing two investigational formulations in healthy male volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Aug 2023
Price :
$35
*
At a glance
- Drugs Dutasteride (Primary)
- Indications Benign prostatic hyperplasia; Prostate cancer; Prostatic intraepithelial neoplasia
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline; GSK
- 07 Jun 2007 New trial record.